Literature DB >> 6826781

Increased erythrocyte superoxide dismutase activities in beta 0-thalassaemia/haemoglobin E and in haemoglobin H diseases.

P Yenchitsomanus, P Wasi.   

Abstract

Erythrocyte superoxide dismutase activities were measured in 45 subjects, 15 each of beta 0-thalassaemia/haemoglobin (Hb) E disease, Hb H disease, and normal. The erythrocyte superoxide dismutase activities were significantly higher in the patients with beta 0-thalassaemia/Hb E and Hb H diseases than in the normal subjects. The increase of erythrocyte superoxide dismutase activities is most likely due to abnormalities specific to thalassaemic red cells rather than an increased number of younger red cells for reticulocytes and nucleated red blood cells did not affect the enzyme activity. Patients with beta 0-thalassaemia/Hb E disease with lower haemoglobin concentration had significantly higher superoxide dismutase activities. In all 45 subjects haemoglobin concentrations and superoxide dismutase activities were inversely correlated (r = -0.60 (p less than 0.001)). This indicates that the amounts of superoxide generated in the red cells may, at least partly, determine severity of red cell damage and thus severity of disease; the increased superoxide dismutase activity in thalassaemia is a response to superoxide generated in greater amounts because of accumulation of excessive globin chains and iron in the red cells. The superoxide dismutase activities in Hb H disease, an alpha-thalassaemic disease, were found to be strikingly increased, higher than in beta 0-thalassaemic disease or other conditions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6826781      PMCID: PMC498206          DOI: 10.1136/jcp.36.3.329

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

Review 1.  Superoxide dismutases.

Authors:  I Fridovich
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Activated oxygen and haemolysis.

Authors:  R W Carrell; C C Winterbourn; E A Rachmilewitz
Journal:  Br J Haematol       Date:  1975-07       Impact factor: 6.998

3.  Superoxide dismutase in red blood cells: method of assay and enzyme content in normal subjects and in patients with beta-thalassemia (major and intermedia).

Authors:  A Concetti; P Massei; G Rotilio; M Brunori; E A Rachmilewitz
Journal:  J Lab Clin Med       Date:  1976-06

4.  Increased glutathione peroxidase activity in alpha-thalassemia.

Authors:  E Beutler; F Matsumoto; D Powars; J Warner
Journal:  Blood       Date:  1977-10       Impact factor: 22.113

5.  Ultrastructural studies in -thalassaemia major.

Authors:  A Polliack; E A Rachmilewitz
Journal:  Br J Haematol       Date:  1973-03       Impact factor: 6.998

6.  The generation of superoxide radical during the autoxidation of hemoglobin.

Authors:  H P Misra; I Fridovich
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

7.  Alpha- and beta-thalassemia in Thailand.

Authors:  P Wasi; S Na-Nakorn; S Pootrakul; M Sookanek; P Disthasongchan; V Panich; M Pornpatkul
Journal:  Ann N Y Acad Sci       Date:  1969-11-20       Impact factor: 5.691

8.  Lipid membrane peroxidation in beta-thalassemia major.

Authors:  E A Rachmilewitz; S B Shohet; B H Lubin
Journal:  Blood       Date:  1976-03       Impact factor: 22.113

9.  The estimation of red cell superoxide dismutase activity.

Authors:  C C Winterbourn; R E Hawkins; M Brian; R W Carrell
Journal:  J Lab Clin Med       Date:  1975-02

10.  Reactions involving superoxide and normal and unstable haemoglobins.

Authors:  C C Winterbourn; B M McGrath; R W Carrell
Journal:  Biochem J       Date:  1976-06-01       Impact factor: 3.857

View more
  5 in total

1.  Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes.

Authors:  Y Yuthavong; P Butthep; A Bunyaratvej; S Fucharoen
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

2.  Effect of Yisui Shengxue Granule () on the oxidative damage of erythrocytes from patients with hemoglobin H disease.

Authors:  Wen-Juan Wang; Zhi-Kui Wu; Xin-Hua Zhang; Yong-Mei Liu; Su-Ping Fang; Chong Zhang; Wen-Jun Liu; Min Li; Rong-Xin Wang; Rui-Gui Luo; Ping-Ping Li
Journal:  Chin J Integr Med       Date:  2012-08-31       Impact factor: 1.978

3.  Comparison of erythrocyte antioxidative enzyme activities between two types of haemoglobin H disease.

Authors:  S Prasartkaew; A Bunyaratvej; S Fucharoen; P Wasi
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

4.  Molecular mechanism of yisui shengxue granule, a complex chinese medicine, on thalassemia patients suffering from hemolysis and anemia of erythrocytes.

Authors:  Na-Li Chu; Zhi-Kui Wu; Xin-Hua Zhang; Su-Ping Fang; Wen-Juan Wang; Yan-Ling Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-10       Impact factor: 2.629

5.  Comment on: oxidative stress and antioxidant status in beta-thalassemia heterozygotes.

Authors:  Hossain Uddin Shekhar
Journal:  Rev Bras Hematol Hemoter       Date:  2013
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.